Your browser doesn't support javascript.
loading
Fetal and Maternal Safety Considerations for In Utero Therapy Clinical Trials: iFeTiS Consensus Statement.
Sagar, Rachel; Almeida-Porada, Graça; Blakemore, Karin; Chan, Jerry K Y; Choolani, Mahesh; Götherström, Cecilia; Jaulent, Agnes; MacKenzie, Tippi C; Mattar, Citra; Porada, Christopher D; Peranteau, William H; Schneider, Holm; Shaw, Steven W; Waddington, Simon N; Westgren, Magnus; David, Anna L.
Afiliação
  • Sagar R; Prenatal Cell and Gene Therapy Group, Elizabeth Garrett Anderson Institute for Women's Health, University College London, London WC1E 6HX, UK.
  • Almeida-Porada G; Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston- Salem, NC 27101, USA.
  • Blakemore K; Division of Maternal-Fetal Medicine, John's Hopkins, Baltimore, MD 21218, USA.
  • Chan JKY; KK Women's and Children's Hospital, Duke-NUS Medical School, Singapore 229899, Singapore.
  • Choolani M; Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
  • Götherström C; Department of Clinical Science, Intervention and Technology, Division of Obstetrics and Gynecology, ANA Futura, Karolinska Institutet, 141 52 Huddinge, Sweden.
  • Jaulent A; EspeRare Foundation, Avenue de Secheron 15, Geneva 1202, Switzerland.
  • MacKenzie TC; Department of Surgery and the Center for Maternal-Fetal Precision Medicine, University of California, San Francisco, San Francisco, CA, USA.
  • Mattar C; Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 119228, Singapore.
  • Porada CD; Institute for Regenerative Medicine, Wake Forest School of Medicine, Winston- Salem, NC 27101, USA.
  • Peranteau WH; Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
  • Schneider H; Department of Paediatrics and Center for Ectodermal Dysplasias, University Hospital Erlangen, Erlangen, Germany.
  • Shaw SW; Department of Obstetrics and Gynecology, Taipei Chang Gung Memorial Hospital, Taipei, Taiwan.
  • Waddington SN; Prenatal Cell and Gene Therapy Group, Elizabeth Garrett Anderson Institute for Women's Health, University College London, London WC1E 6HX, UK; Wits/SAMRC Antiviral Gene Therapy Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Westgren M; Department of Clinical Science, Intervention and Technology, Division of Obstetrics and Gynecology, ANA Futura, Karolinska Institutet, 141 52 Huddinge, Sweden.
  • David AL; Prenatal Cell and Gene Therapy Group, Elizabeth Garrett Anderson Institute for Women's Health, University College London, London WC1E 6HX, UK; NIHR University College London Hospitals Biomedical Research Centre, 149 Tottenham Court Road, London W1T 7DN, UK; Department of Development and Regeneration
Mol Ther ; 28(11): 2316-2319, 2020 11 04.
Article em En | MEDLINE | ID: mdl-33069884

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Terapias Fetais Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ensaios Clínicos como Assunto / Terapias Fetais Idioma: En Ano de publicação: 2020 Tipo de documento: Article